These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1867659)

  • 1. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin.
    Marastoni M; Salvadori S; Balboni G; Scaranari V; Santagada V; Romualdi P; Ferri S; Tomatis R
    Arzneimittelforschung; 1991 Mar; 41(3):240-3. PubMed ID: 1867659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides.
    Marastoni M; Scaranari V; Romualdi P; Donatini A; Ferri S; Tomatis R
    Arzneimittelforschung; 1993 Sep; 43(9):997-1000. PubMed ID: 8240467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414
    [No Abstract]   [Full Text] [Related]  

  • 4. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
    Märki F; Pfeilschifter J; Rink H; Wiesenberg I
    FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action.
    Facchiano A; Cordella-Miele E; Miele L; Mukherjee AB
    Life Sci; 1991; 48(5):453-64. PubMed ID: 1992287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of synthetic peptides from annexin I and uteroglobin with lipid monolayers and their effect on phospholipase A2 activity.
    Newman RH; Freemont PS; Barton GJ; Crumpton MJ
    Biochem Soc Trans; 1990 Dec; 18(6):1233-4. PubMed ID: 2150950
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nonapeptide fragments of uteroglobin and lipocortin I on oedema and mast cell degranulation.
    Lloret S; Moreno JJ
    Eur J Pharmacol; 1994 Nov; 264(3):379-84. PubMed ID: 7535228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins.
    Lloret S; Moreno JJ
    Biochem Pharmacol; 1992 Oct; 44(7):1437-41. PubMed ID: 1417964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anti-inflammatory peptide from human lipocortin 5.
    Perretti M; Becherucci C; Mugridge KG; Solito E; Silvestri S; Parente L
    Br J Pharmacol; 1991 Jun; 103(2):1327-32. PubMed ID: 1832064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.
    Cabré F; Moreno JJ; Carabaza A; Ortega E; Mauleón D; Carganico G
    Biochem Pharmacol; 1992 Aug; 44(3):519-25. PubMed ID: 1387313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.
    Moreno JJ
    Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiflammins inhibit synthesis of platelet-activating factor and intradermal inflammatory reactions.
    Camussi G; Tetta C; Baglioni C
    Adv Exp Med Biol; 1990; 279():161-72. PubMed ID: 2096695
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins).
    Ialenti A; Doyle PM; Hardy GN; Simpkin DS; Di Rosa M
    Agents Actions; 1990 Jan; 29(1-2):48-9. PubMed ID: 2139299
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of antiflammins on endotoxin-induced uveitis in rats.
    Chan CC; Ni M; Miele L; Cordella-Miele E; Ferrick M; Mukherjee AB; Nussenblatt RB
    Arch Ophthalmol; 1991 Feb; 109(2):278-81. PubMed ID: 1993038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphlogistic effectiveness of combinations of inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases of the arachidonic acid cascade].
    Bekemeier H; Hirschelmann R
    Pharmazie; 1986 Apr; 41(4):260-2. PubMed ID: 3088612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1.
    Cirino G; Cicala C; Sorrentino L; Ciliberto G; Arpaia G; Perretti M; Flower RJ
    Br J Pharmacol; 1993 Mar; 108(3):573-4. PubMed ID: 8467352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities.
    Hope WC; Patel BJ; Bolin DR
    Agents Actions; 1991 Sep; 34(1-2):77-80. PubMed ID: 1793057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural homology between uteroglobin and the pore-forming domain of colicin A suggests a possible mechanism of action for uteroglobin.
    de la Cruz X; Lee B
    Protein Sci; 1996 May; 5(5):857-61. PubMed ID: 8732757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of allergic and non-allergic inflammation by phospholipase A2 inhibitors.
    Tibes U; Vondran A; Rodewald E; Friebe WG; Schäfer W; Scheuer W
    Int Arch Allergy Immunol; 1995; 107(1-3):432-4. PubMed ID: 7613203
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
    Wang P; Li Y; Shao Q; Zhou W; Wang K
    J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.